UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy

The Journal of clinical investigation, 2016-07, Vol.126 (7), p.2519-2532

2016

Volltextzugriff (PDF)

Cardiac tamponade following aortic root erosion by an Amplatzer PFO-Occluder in a 41-year-old woman: Only a matter of sizing?

Journal of cardiology cases, 2021-03, Vol.23 (3), p.123-126

2021

Volltextzugriff (PDF)

Giant Aneurysm of the Right Coronary Artery

JACC. Case reports, 2021-05, Vol.3 (5), p.778-779

2021

Volltextzugriff (PDF)

Pregnancy-associated thrombotic thrombocytopenic purpura

Thrombosis and haemostasis, 2009-02, Vol.101 (2), p.248-251

2009

Volltextzugriff (PDF)

Rituximab for the second- and thirdline therapy of idiopathic membranous nephropathy: a prospective single center study using a new treatment strategy

Clinical nephrology, 2013-08, Vol.80 (8), p.105-113

2013

Volltextzugriff (PDF)

Kombinierte Immunsuppression mit Cyclosporin A, Mycophenolatmofetil (MMF) und Dexamethason zur Aktivitätskontrolle einer rezidivierten, sekundären hämophagozytischen Lymphohistiozytose (sHLH) auf dem Boden eines systemischen Lupus erythematodes (SLE)

Innere Medizin (Heidelberg, Germany), 2024, Vol.65 (8), p.843-849

2024

Volltextzugriff (PDF)

Screening and Differential Diagnosis of Renal Light Chain-Associated Diseases

Kidney & blood pressure research, 2012-01, Vol.35 (2), p.120-128

2012

Volltextzugriff (PDF)

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2023-03, Vol.21 (3), p.559-572

2023

Volltextzugriff (PDF)

Percutaneous balloon pericardiotomy: efficacy in a series of malignant and nonmalignant cases

Scandinavian cardiovascular journal : SCJ, 2022-12, Vol.56 (1), p.331-336

2022

Volltextzugriff (PDF)

Combined immunosuppression with cyclosporin A, mycophenolate mofetil (MMF) and dexamethasone for activity control of recurrent secondary hemophagocytic lymphohistiocytosis (sHLH) with underlying systemic lupus erythematosus (SLE)

Innere Medizin (Heidelberg, Germany), 2024-08, Vol.65 (8), p.843

2024

Volltextzugriff (PDF)

Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura

Blood advances, 2020-07, Vol.4 (13), p.3085-3092

2020

Volltextzugriff (PDF)

Kidney Biopsy Findings in Patients with SARS-CoV-2 Infection or After COVID-19 Vaccination

Clinical journal of the American Society of Nephrology, 2023-05, Vol.18 (5), p.613-625

2023

Volltextzugriff (PDF)

Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study

Cardiovascular drugs and therapy, 2024-02, Vol.38 (1), p.119-129

2024

Volltextzugriff (PDF)

Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report

Journal of medical case reports, 2009-11, Vol.3 (1), p.120-120, Article 120

2009

Volltextzugriff (PDF)

Giant Aneurysm of the Right Coronary Artery: Multimodality Imaging and Interventional Management

JACC. Case reports, 2021-05, Vol.3 (5), p.778-779

2021

Volltextzugriff (PDF)

ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP

Blood advances, 2020-07, Vol.4 (13), p.3093-3101

2020

Volltextzugriff (PDF)

Organoid single cell profiling identifies a transcriptional signature of glomerular disease

JCI insight, 2019-01, Vol.4 (1)

2019

Volltextzugriff (PDF)

Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein

Kidney international, 2004-07, Vol.66 (1), p.338-347

2004

Volltextzugriff (PDF)

Rituximab for the second- and third-line therapy of idiopathic membranous nephropathy: a prospective single center study using a new treatment strategy

Clinical nephrology, 2013-08, Vol.80 (2), p.105

2013

Volltextzugriff (PDF)

The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension

American journal of kidney diseases, 2006-10, Vol.48 (4), p.571-579

2006

Volltextzugriff (PDF)

Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin II

Kidney international, 2002-01, Vol.61 (1), p.68-79

2002

Volltextzugriff (PDF)

The Advanced Glycation End Product N ε-Carboxymethyllysine Is Not a Predictor of Cardiovascular Events and Renal Outcomes in Patients With Type 2 Diabetic Kidney Disease and Hypertension

American journal of kidney diseases, 2006-10, Vol.48 (4), p.571-579

2006

Volltextzugriff (PDF)

Proteinuria after conversion to sirolimus in kidney transplant recipients: impact of pre-existing proteinuria, graft function, and angiotensin-converting enzyme inhibitors/angiotensin-receptor antagonists

Clinical transplantation, 2010-09, Vol.24 (5), p.626-630

2010

Volltextzugriff (PDF)

Eosinophilie – eine differentialdiagnostische Herausforderung

Medizinische Klinik (München. 1983), 2008-08, Vol.103 (8), p.591-597

2008

Volltextzugriff (PDF)

Wechsel zwischen BK-Virus-Nephropathie und Abstoßung – der frustrane Verlauf einer Lebendnierenspende

Medizinische Klinik (München. 1983), 2009-08, Vol.104 (8), p.644-648

2009

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(61)

Publikationsform

Sprache

Englisch
(57)
Deutsch
(15)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy

Cardiac tamponade following aortic root erosion by an Amplatzer PFO-Occluder in a 41-year-old woman: Only a matter of sizing?

Giant Aneurysm of the Right Coronary Artery

Pregnancy-associated thrombotic thrombocytopenic purpura

Rituximab for the second- and thirdline therapy of idiopathic membranous nephropathy: a prospective single center study using a new treatment strategy

Kombinierte Immunsuppression mit Cyclosporin A, Mycophenolatmofetil (MMF) und Dexamethason zur Aktivitätskontrolle einer rezidivierten, sekundären hämophagozytischen Lymphohistiozytose (sHLH) auf dem Boden eines systemischen Lupus erythematodes (SLE)

Screening and Differential Diagnosis of Renal Light Chain-Associated Diseases

Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura

Percutaneous balloon pericardiotomy: efficacy in a series of malignant and nonmalignant cases

Combined immunosuppression with cyclosporin A, mycophenolate mofetil (MMF) and dexamethasone for activity control of recurrent secondary hemophagocytic lymphohistiocytosis (sHLH) with underlying systemic lupus erythematosus (SLE)

Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura

Kidney Biopsy Findings in Patients with SARS-CoV-2 Infection or After COVID-19 Vaccination

Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study

Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report

Giant Aneurysm of the Right Coronary Artery: Multimodality Imaging and Interventional Management

ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP

Organoid single cell profiling identifies a transcriptional signature of glomerular disease

Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein

Rituximab for the second- and third-line therapy of idiopathic membranous nephropathy: a prospective single center study using a new treatment strategy

The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension

Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin II

The Advanced Glycation End Product N ε-Carboxymethyllysine Is Not a Predictor of Cardiovascular Events and Renal Outcomes in Patients With Type 2 Diabetic Kidney Disease and Hypertension

Proteinuria after conversion to sirolimus in kidney transplant recipients: impact of pre-existing proteinuria, graft function, and angiotensin-converting enzyme inhibitors/angiotensin-receptor antagonists

Eosinophilie – eine differentialdiagnostische Herausforderung

Wechsel zwischen BK-Virus-Nephropathie und Abstoßung – der frustrane Verlauf einer Lebendnierenspende

Suchergebnisse filtern